Comser Pharma | COMSER Pharma

COMSER is a CDMO specializing in lyophilization and liquid injectables for the biopharmaceutical and biotechnology industries. Located in Terrassa (Barcelona, Spain), the company offers services ranging from formulation development and lyophilization process optimization to scale-up and technology transfer.

The company has extensive expertise in developing lyophilization processes for both small and large molecules, including high-potency APIs up to OEB 5.

COMSER is currently building a GMP manufacturing facility for small-scale production of preclinical and Phase I–II clinical batches, scheduled to become fully operational by the end of 2027. With a strong focus on poorly stable injectable formulations requiring lyophilization, the company acts as a technical partner for biotech companies throughout product development.

Manufacturing Capacity (depending on vial format)

• 4,732 vials (2R, 3R, 4R)
• 2,420 vials (6R, 8R)
• 2,016 vials (10R, 15R)
• 1,276 vials (20R, 25R, 30R)
• 760 vials (50R)
• 504 vials (100R)